Revenue, Concentrations and Geographic Information (Tables)

3 Months Ended

Mar. 31, 2026

Revenue, Concentrations and Geographic Information

Schedule of disaggregation of revenue by revenue type

The following table presents revenue by major types of revenue for the three months ended March 31, 2026 and 2025 (in thousands):

	Three Months Ended
	March 31,
	2026		2025
BioLogistics Solutions	$	21,668	$	18,531
BioStorage/BioServices		5,230		4,334
Life Sciences Services		26,898		22,865
Life Sciences Products		20,900		18,175
Total revenue	$	47,798	$	41,040

Schedule of geographical revenues, by origin

Our geographical revenue, by origin, for the three months ended March 31, 2026 and 2025, was as follows (in thousands):

	Three Months Ended
	March 31,
	2026		2025
Americas	$	34,958	$	32,195
Europe, the Middle East, and Africa (EMEA)		8,951		5,580
Asia-Pacific (APAC)		3,889		3,265
Total revenue	$	47,798	$	41,040

Schedule of roll-forward of the allowance for credit losses

	March 31,		December 31,
	2026		2025
Balance of allowance for credit losses, beginning of period	$	1,141	$	878
Change in expected credit losses		18		263
Write-offs, net of recoveries		—		—
Balance of allowance for credit losses, end of period	$	1,159	$	1,141